Inhibition of the PI3K/AKT signal could decrease the levels of CyclinB1 and CDK1, thereby causing the G2/M cell cycle arrest in HCC cells and bladder cancer cells [36, 37]. Here, CDK1 is linked to hepatocellular carcinoma.